This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2005 Jun 30;352(26):2743-6.

doi: 10.1056/NEJMe058119.

The maze of treatments for hepatitis B

Anna Suk-Fong Lok

PMID: 15987924
DOI: 10.1056/NEJMe058119

Editorial

The maze of treatments for hepatitis B

Anna Suk-Fong Lok. N Engl J Med. 2005.

. 2005 Jun 30;352(26):2743-6.

doi: 10.1056/NEJMe058119.

Author

Anna Suk-Fong Lok

PMID: 15987924
DOI: 10.1056/NEJMe058119

No abstract available

PubMed Disclaimer

Comment on

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.
Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Ma J, Arterburn S, Xiong S, Currie G, Brosgart CL; Adefovir Dipivoxil 438 Study Group. Hadziyannis SJ, et al. N Engl J Med. 2005 Jun 30;352(26):2673-81. doi: 10.1056/NEJMoa042957. N Engl J Med. 2005. PMID: 15987916 Clinical Trial.
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G, Gane E, Fried MW, Chow WC, Paik SW, Chang WY, Berg T, Flisiak R, McCloud P, Pluck N; Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group. Lau GK, et al. N Engl J Med. 2005 Jun 30;352(26):2682-95. doi: 10.1056/NEJMoa043470. N Engl J Med. 2005. PMID: 15987917 Clinical Trial.

Similar articles

[Protocol for the treatment of chronic viral hepatitis].
Dalmi L, Gervain J, Horváth G, Hunyady B, Ibrányi E, Makara M, Pár A, Szalay F, Tornai I, Telegdy L; Gasztroenterológiai Szakmai Kollégium; Infektológiai Szakmai Kollégium. Dalmi L, et al. Orv Hetil. 2008 Jan 20;149(3):129-35. doi: 10.1556/OH.2008.28287. Orv Hetil. 2008. PMID: 18194921 Hungarian. No abstract available.
Peginterferon and lamivudine for hepatitis B.
Assy NN, Hussein O. Assy NN, et al. N Engl J Med. 2004 Dec 30;351(27):2879; author reply 2879. doi: 10.1056/NEJM200412303512720. N Engl J Med. 2004. PMID: 15625344 No abstract available.
Treatment with interferons (including pegylated interferons) in patients with hepatitis B.
Cooksley WG. Cooksley WG. Semin Liver Dis. 2004;24 Suppl 1:45-53. doi: 10.1055/s-2004-828678. Semin Liver Dis. 2004. PMID: 15192801 Review.
Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.
Colle I, Adler M, Brenard R, Henrion J, Langlet P, Michielsen P, Orlent H, Reynaert H, Sprengers D, Stärkel P, Van Damme P, Verslype C, Delwaide J; Belgian Association for the Study of the Liver. Colle I, et al. Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):389-420. Acta Gastroenterol Belg. 2007. PMID: 18330099 No abstract available.
[Pharmacological agents for the treatment of chronic hepatitis B].
Sánchez-Tapias JM. Sánchez-Tapias JM. Gastroenterol Hepatol. 2008 Mar;31(3):120-8. doi: 10.1157/13116500. Gastroenterol Hepatol. 2008. PMID: 18341843 Review. Spanish. No abstract available.

See all similar articles

Cited by

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.
Whitacre DC, Peters CJ, Sureau C, Nio K, Li F, Su L, Jones JE, Isogawa M, Sallberg M, Frelin L, Peterson DL, Milich DR. Whitacre DC, et al. Hum Vaccin Immunother. 2020;16(2):251-268. doi: 10.1080/21645515.2019.1689745. Epub 2019 Dec 6. Hum Vaccin Immunother. 2020. PMID: 31809638 Free PMC article.
Immunotherapy for Chronic Hepatitis B using HBsAg-based Vaccine Formulations: From Preventive Commercial Vaccines to Therapeutic Approach Julio Cesar Aguilar.
Cesar Aguilar J, Y L. Cesar Aguilar J, et al. Euroasian J Hepatogastroenterol. 2014 Jul-Dec;4(2):92-97. doi: 10.5005/jp-journals-10018-1109. Epub 2014 Jul 28. Euroasian J Hepatogastroenterol. 2014. PMID: 29699355 Free PMC article. Review.
Mutational analysis of reverse transcriptase and surface proteins of patients with partial virological response during mono and combination antiviral therapies in genotype D chronic hepatitis B.
Mahabadi M, Alavian SM, Norouzi M, Keyvani H, Mahmoudi M, Jazayeri SM. Mahabadi M, et al. Electron Physician. 2016 Jun 25;8(6):2466-74. doi: 10.19082/2466. eCollection 2016 Jun. Electron Physician. 2016. PMID: 27504160 Free PMC article.
A Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection.
Zeng DW, Zhang JM, Liu YR, Dong J, Jiang JJ, Zhu YY. Zeng DW, et al. Medicine (Baltimore). 2016 Feb;95(8):e2503. doi: 10.1097/MD.0000000000002503. Medicine (Baltimore). 2016. PMID: 26937895 Free PMC article.
Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection.
Lun-Gen L. Lun-Gen L. J Clin Transl Hepatol. 2014 Sep;2(3):197-201. doi: 10.14218/JCTH.2014.00022. Epub 2014 Sep 15. J Clin Transl Hepatol. 2014. PMID: 26355652 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.